Inactivation of the E-Prostanoid 3 Receptor Attenuates the Angiotensin II Pressor Response via Decreasing Arterial Contractility

被引:54
作者
Chen, Lihong [1 ,2 ]
Miao, Yifei [1 ,2 ]
Zhang, Yahua
Dou, Dou [1 ]
Liu, Limei [1 ]
Tian, Xiaoyu [4 ]
Yang, Guangrui [1 ,2 ]
Pu, Dan [1 ,2 ]
Zhang, Xiaoyan [1 ,2 ]
Kang, Jihong [1 ,2 ]
Gao, Yuansheng
Wang, Shigiang [5 ]
Breyer, Matthew D. [3 ]
Wang, Nanping [2 ]
Zhu, Yi [1 ,2 ,3 ]
Huang, Yu [4 ]
Breyer, Richard M. [3 ]
Guan, Youfei
机构
[1] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing 100191, Peoples R China
[2] Minist Educ, Key Lab Cardiovasc Sci, Beijing, Peoples R China
[3] Vanderbilt Univ, Med Ctr, Dept Med, Div Nephrol & Hypertens, Nashville, TN USA
[4] Chinese Univ Hong Kong, Sch Biomed Sci, Li Ka Shing Inst Hlth Sci, Inst Vasc Med, Shatin, Hong Kong, Peoples R China
[5] Peking Univ, Inst Life Sci, Beijing 100191, Peoples R China
基金
美国国家卫生研究院;
关键词
angiotensin II; calcium; E-prostanoid; 3; hypertension; vasoconstriction; C-TERMINAL TAIL; BLOOD-PRESSURE; EP3; RECEPTOR; PROSTAGLANDIN RECEPTORS; MICE LACKING; SUBTYPE; EXPRESSION; HYPERTENSION; ISOFORMS; CALCIUM;
D O I
10.1161/ATVBAHA.112.254052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective-The present studies aimed a elucidating the role of prostaglandin E-2 receptor subtype 3 (E-prostanoid [EP] 3) in regulating blood pressure. Methods and Results-Mice bearing a genetic disruption of the EP3 gene (EP3-/-) exhibited reduced baseline mean arterial pressure monitored by both tail-cuff and carotid arterial catheterization. The pressor responses induced by EP3 agonists M&B28767 and sulprostone were markedly attenuated in EP3(-/-) mice, whereas the reduction of blood pressure induced by prostaglandin E-2 was comparable in both genotypes. Vasopressor effect of acme or chronic infusion of angiotensin II (Ang II) was attenuated in EP3(-/-) mice. Ang II-induced vasoconstriction in mesenteric arteries decreased in EP3(-/-) group. In mesenteric arteries from wild-type mice, Ang II-induced vasoconstriction was inhibited by EP3 selective antagonist DG-041 or L798106. The expression of Arhgef-1 is attenuated in EP3 deficient mesenteric arteries. EP3 antagonist DG-041 diminished Ang II-induced phosphorylation of myosin light chain 20 and myosin phosphatase target subunit 1 in isolated mesenteric arteries. Furthermore, in vascular smooth muscle cells, Ang II induced intracellular Ca2+ increase was potentiated by EP3 agonist sulprostone but inhibited by DG-041. Conclusion-Activation of the EP3 receptor raises baseline blood pressure and contributes to Ang II dependent hypertension a least partially via enhancing Ca2+ sensitivity and intracellular calcium concentration in vascular smooth muscle cells. Selective targeting of the EP3 receptor may represent a potential therapeutic target for the treatment of hypertension. (Arterioscler Thromb Vasc Biol. 2012;32:3024-3032.)
引用
收藏
页码:3024 / +
页数:22
相关论文
共 51 条
[51]   Targeted Disruption of the Prostaglandin E2 E-Prostanoid 2 Receptor Exacerbates Vascular Neointimal Formation in Mice [J].
Zhu, Sen ;
Xue, Rui ;
Zhao, Pan ;
Fan, Fen-Ling ;
Kong, Xiaomu ;
Zheng, Senfeng ;
Han, Qifei ;
Zhu, Yi ;
Wang, Nanping ;
Yang, Jichun ;
Guan, Youfei .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2011, 31 (08) :1739-U83